Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
66 | 3 | NEUROSCIENCES//PSYCHOPHARMACOLOGY//DOPAMINE | 89085 |
630 | 2 | PREPULSE INHIBITION//PHENCYCLIDINE//KETAMINE | 14148 |
6924 | 1 | PHENCYCLIDINE//METAPHIT//CAS 956 90 1 | 1454 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PHENCYCLIDINE | authKW | 510483 | 10% | 16% | 144 |
2 | METAPHIT | authKW | 456100 | 2% | 96% | 22 |
3 | CAS 956 90 1 | authKW | 132753 | 0% | 88% | 7 |
4 | JOURNAL OF PSYCHEDELIC DRUGS | journal | 107718 | 1% | 38% | 13 |
5 | PHENCYCLIDINE DERIVATIVES | authKW | 86697 | 0% | 100% | 4 |
6 | RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE | journal | 66241 | 2% | 9% | 33 |
7 | CNS 5161 | authKW | 65023 | 0% | 100% | 3 |
8 | PHENCYCLIDINE RECEPTOR | authKW | 52011 | 0% | 40% | 6 |
9 | TAIL IMMERSION TEST | authKW | 50147 | 1% | 26% | 9 |
10 | BTCP | authKW | 48265 | 0% | 32% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 12023 | 53% | 0% | 766 |
2 | Neurosciences | 3925 | 31% | 0% | 455 |
3 | Behavioral Sciences | 1718 | 8% | 0% | 118 |
4 | Substance Abuse | 1688 | 5% | 0% | 76 |
5 | Chemistry, Medicinal | 1141 | 9% | 0% | 130 |
6 | Psychiatry | 498 | 8% | 0% | 112 |
7 | Toxicology | 241 | 5% | 0% | 67 |
8 | Medicine, Research & Experimental | 218 | 6% | 0% | 84 |
9 | Psychology, Clinical | 50 | 2% | 0% | 26 |
10 | Chemistry, Analytical | 37 | 4% | 0% | 55 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACOL PHARMACOCINET | 28890 | 0% | 22% | 6 |
2 | 1 WAKEFIELD ST | 21674 | 0% | 100% | 1 |
3 | A STAR NUS | 21674 | 0% | 100% | 1 |
4 | ANIM EXPT PLATFORM | 21674 | 0% | 100% | 1 |
5 | BLDG 8 | 21674 | 0% | 100% | 1 |
6 | BRAIN IMAGING NEUROL DISABIL | 21674 | 0% | 100% | 1 |
7 | BRAIN IMAGING NEUROL DISABIL UMR 825 | 21674 | 0% | 100% | 1 |
8 | CHEVRON SCI BEHAV NEUROSCI | 21674 | 0% | 100% | 1 |
9 | CI N SLDM TEP | 21674 | 0% | 100% | 1 |
10 | CLIN ELE OPHYSIOL BEHAV | 21674 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF PSYCHEDELIC DRUGS | 107718 | 1% | 38% | 13 |
2 | RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE | 66241 | 2% | 9% | 33 |
3 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 13094 | 6% | 1% | 87 |
4 | RESEARCH COMMUNICATIONS IN ALCOHOL AND SUBSTANCES OF ABUSE | 12592 | 0% | 12% | 5 |
5 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 9348 | 7% | 0% | 96 |
6 | NEUROPHARMACOLOGY | 8886 | 4% | 1% | 63 |
7 | EUROPEAN JOURNAL OF PHARMACOLOGY | 8337 | 7% | 0% | 105 |
8 | LIFE SCIENCES | 5437 | 5% | 0% | 72 |
9 | PSYCHOPHARMACOLOGY | 3521 | 3% | 0% | 45 |
10 | JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2517 | 2% | 1% | 23 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |